346
Participants
Start Date
June 30, 2009
Primary Completion Date
August 31, 2010
Study Completion Date
September 30, 2010
Gestodene/EE (FC Patch Low, BAY86-5016)
21-day regimen per cycle (1 patch a week for 3 weeks followed by a 7-day patch-free period) for 7 cycles and placebo tablets matching the conditions of the treatment of Arm 2
Oral contraceptive (equivalent to the active treatment tablets of Levlite), 21-day blister SH D00593A
21-day regimen per cycle (1 tablet a day for 3 weeks followed by a 7-day tablet-free period) for 7 cycles and placebo patches matching the conditions of the treatment of Arm 1
Wexford
Pittsburgh
Philadelphia
Richmond
Winston-Salem
Columbia
Decatur
Atlanta
Daytona Beach
Miami
Lake Worth
Clearwater
Leesburg
Cincinnati
Kalamazoo
La Crosse
St Louis
Metairie
Phoenix
Glendale
Tucson
Las Vegas
San Diego
Anaheim
Renton
Seattle
Chandler
New Brunswick
Lead Sponsor
Bayer
INDUSTRY